The FDA drug recall list for 2026 is not one frozen spreadsheet. FDA maintains a current drug-announcement page, broader Enforcement Reports and downloadable data. To check medicine in your possession, compare the exact drug, labeler or manufacturer, strength, dosage form, NDC, lot number and expiration date with the official record. A shared brand or generic name alone is not a match.
Do not stop a prescribed or medically necessary medicine without guidance from your pharmacist or clinician. Product Recall Checker is independent and does not replace FDA, the recalling company, your pharmacy or professional medical advice.
Where to check the FDA drug recall list in 2026
Start with FDA's Drug Recalls page when you need a readable company announcement. The table can be searched by product, brand or company and shows the announcement date, product description, reason and whether FDA identifies the recall as terminated. Open the notice itself for affected lots and instructions; the row is only a summary.
Next search the Enforcement Reports if a pharmacy message or news report does not appear in the public table. FDA states that all recalls it monitors are included once classified. Since 2017, eligible actions can also appear as “not yet classified” while FDA evaluates them. The general announcement feed is narrower because not every recall receives a press release.
| Source | Best use | Do not assume |
|---|---|---|
| Drug Recalls announcements | Consumer-facing details and contacts | That every enforcement action has a notice |
| Enforcement Reports | Classified and pending-classification records | That report date equals first company contact |
| openFDA download | Bulk analysis and reproducible searches | That a saved file remains current |
Use our latest recall index for navigation, but save the FDA URL used for your decision. Machine-readable openFDA data is valuable for analysts, yet FDA warns that updates can revise older records. For a patient, the newest official notice and pharmacy trace are more useful than a downloaded list with no label comparison.
How to match your medication by NDC, lot and expiration
FDA's patient guidance makes the lot number central: compare the lot on your label or package with the recalled lot in the notification. Also compare the manufacturer or labeler, drug name, strength, dosage form, package configuration, NDC and expiration date whenever the notice uses them to limit scope.
An NDC normally has three segments representing the labeler, product and package. It is not a batch number. The same NDC may appear on many lots made over time, so an NDC match with a lot mismatch can mean the package is outside the announced range. Conversely, formatting can drop leading zeroes or insert hyphens differently; compare digits and segment context rather than guessing.
- Copy the product name, manufacturer or labeler, strength and form.
- Copy the full NDC exactly as displayed and note its formatting.
- Find the lot/batch and expiration on the manufacturer bottle, carton, blister, vial or syringe.
- Compare each field with the official notice and any attached product table.
- If your pharmacy container lacks a lot, ask the dispensing pharmacy to trace the stock used for your prescription.
Do not post a prescription label publicly because it may expose your name, prescription number or other personal information. Photograph it privately if the pharmacy or manufacturer needs evidence. If a code is smudged or missing, treat the match as unresolved—not positive or negative—until an authorized source checks it.
Selected 2026 drug recall examples—and how not to overread them
The following examples were checked on September 3, 2026. They illustrate why product and lot details matter; they are not a complete list of current drug recalls.
| FDA publish date | Officially described product | Announced scope/reason |
|---|---|---|
| August 28, 2026 | B. Braun 0.9% Sodium Chloride Injection USP, 100 mL in 150 mL PAB container | Three lots; particulate matter identified as iron oxide |
| August 20, 2026 | Optimal Balance compounded glutathione injection 200 mg/mL, 30 mL multi-dose vial | One lot; elevated endotoxin |
| July 24, 2026 | Sunny Pharmtech cyclophosphamide injection, 1 g/vial and 2 g/vial | Three lots; particulate matter identified as steel |
The first example did not cover every bag of saline. FDA's posted B. Braun announcement specified a container configuration and three lots, and noted that the recall reason was corrected to identify iron oxide. That update shows why copied summaries can become stale.
The glutathione notice concerned one identified lot of a compounded concentration and vial size—not every glutathione product or every preparation from every pharmacy. Likewise, the cyclophosphamide announcement named strengths and three lots. Its instructions explicitly told patients not to stop or change prescribed treatment without consulting a healthcare professional.
Never extrapolate from a reason such as “particulate matter” to a different medicine, manufacturer or lot. Open the linked notice, expand any product table, compare your label and check whether FDA later updated scope, risk information or status.
Recall class, depth and status are different fields
A drug record can contain three separate signals. Class expresses FDA's health-hazard evaluation: Class I involves a reasonable probability of serious consequences or death; Class II involves temporary or reversible consequences, or a remote probability of serious harm; Class III means adverse health consequences are unlikely. It is not a forecast of what will happen to a particular patient.
Depth describes how far into distribution the recall strategy reaches. Consumer or user level can include patients and healthcare users; retail level can involve pharmacies and other dispensing locations; wholesale level addresses distribution before retail. A wholesale-level action is not automatically “low risk,” and a consumer-level action is not automatically Class I. Read the official strategy and recipient instructions.
Status describes recall progress. “Not yet classified” means class assignment is pending, not that the firm did nothing. FDA uses “terminated” after determining reasonable efforts were made to remove or correct the product and proper disposition was achieved under the strategy. A terminated recall remains historically valid; an old unit that matches does not become usable simply because the administrative process ended.
Other FDA terms also have boundaries. A market withdrawal generally concerns a minor violation or no violation subject to FDA legal action, while a stock recovery concerns product that has not left the firm's direct control. A drug safety communication can warn about a risk or labeling change without announcing a lot-specific recall. Preserve the official label instead of converting every drug notice into a recall.
What to do if your prescription lot matches
Call the dispensing pharmacy and, when treatment decisions are involved, the prescriber. Tell them the exact drug, strength, dosage form, NDC, lot, expiration and FDA notice date. Ask whether your dispensed supply came from the affected inventory and what the official instructions require. Keep taking or using the medicine as directed unless the recall notice or a healthcare professional tells you otherwise.
- Preserve evidence: keep the bottle, carton, blister or vial and photograph the codes privately.
- Protect continuity: tell the pharmacy how many doses remain and when the next dose is due.
- Follow the stated remedy: use the company or pharmacy process in the notice; a refund, exchange or replacement is not automatic across recalls.
- Separate the product: prevent accidental use while following professional instructions, but store it under required temperature and security conditions.
- Document contacts: record the date, representative, case number and disposition.
Do not throw a recalled medicine into household trash, pour it down a drain or flush it unless the official instructions and FDA disposal guidance support that method. FDA generally recommends authorized drug take-back options; only medicines on the agency's limited flush list use that fallback when take-back is unavailable.
If you have a serious symptom or reaction, seek appropriate care first. Patients and professionals can submit adverse-event and product-quality reports through MedWatch. Reporting does not prove the drug caused an event and should never delay emergency assistance.
OTC, compounded and clinic-administered products
Over-the-counter medicine is often easiest to check because the original carton and bottle remain with the consumer. Compare the active ingredient, strength, dosage form, flavor when relevant, package count, NDC, lot and expiration. Store-brand products can share an underlying manufacturer, but a supplier relationship does not let you add an unlisted retailer or UPC to the recall.
Compounded medicines require a different paper trail. FDA explains that compounded drugs are not FDA-approved and the agency does not verify their safety, effectiveness or quality before marketing. That fact does not mean every compounded preparation is recalled. Check the compounding pharmacy name, exact concentration, volume, dosage form, prescription label, lot or prescription-specific identifier and beyond-use date against the notice. Contact the pharmacy that prepared or dispensed it.
For a medicine administered in a hospital, imaging center, infusion clinic or physician's office, you may never see the manufacturer carton. Official notices may describe a hospital, healthcare-facility or user-level recall. Give the facility the date and location of treatment, product name if known, and your visit or medical-record information through a secure channel. Ask its pharmacy, materials-management or patient-safety staff to compare purchasing and administration records with the recalled lots.
A clinic-level recall does not prove that your dose came from an affected lot or that you were harmed. It does justify a trace request when the product and treatment period plausibly overlap. If follow-up monitoring is recommended, the treating professional should explain why, what symptoms or tests matter, and whether the official notice changes future treatment.
How pharmacists and healthcare facilities trace recalled lots
A pharmacy may repackage tablets from a manufacturer bottle into a patient container, so the printed prescription label can show drug and NDC information without the original lot. The pharmacy can compare dispensing date, wholesaler information, inventory receipts, stock rotation and remaining bottles to determine whether affected inventory could have supplied the prescription. A clinic can perform a similar trace through purchasing, storage and administration records.
The Drug Supply Chain Security Act establishes tracing and product-identification requirements for many prescription drugs as they move among authorized trading partners. Those systems support investigations, but a consumer should not assume that typing an NDC into a public search exposes the complete transaction trail. The pharmacy or facility works through its secure records and trading partners.
When calling, provide a focused request: “FDA posted a recall for this manufacturer and product; can you confirm whether my prescription filled on this date came from one of the listed lots?” Ask how the pharmacy will notify you, whether the prescriber must authorize an alternative and what to do with the existing supply. If staff cannot answer immediately, request a case or callback reference.
FDA reviews how effectively a firm notifies customers and removes defective product, but the recalling company executes the recall strategy. That is why messages may arrive through several routes. Verify any unexpected text or email by independently calling the pharmacy number on your usual records or using the contact in the FDA notice; do not use a link that asks for payment, passwords or verification codes.
FDA drug recall list 2026 FAQ
Does a recall of one generic manufacturer affect every generic version?
No. Generic name alone is not the scope. Compare labeler or manufacturer, strength, dosage form, NDC, lot and expiration exactly as the notice specifies.
What if my prescription bottle has no lot number?
Do not guess from the fill date. Ask the dispensing pharmacy to trace its inventory and wholesaler records. Provide the FDA notice, NDC if visible and prescription fill date through a secure channel.
What if I already took medicine from a recalled lot?
A match does not prove injury. Contact the pharmacist or clinician for advice based on the notice and your treatment. Seek urgent care for serious symptoms, and use MedWatch to report an event after immediate needs are addressed.
Is a drug safety warning the same as a lot recall?
No. FDA may issue safety communications, labeling changes, alerts, withdrawals or shortage notices without a lot-specific recall. Use the agency's exact term and instructions.
Can a terminated recall be ignored?
Termination describes FDA's oversight status after reasonable recall efforts and proper disposition; it does not make a matching old package acceptable for use. Ask the pharmacy how to handle it.
How current is this article?
The examples and sources were checked September 3, 2026. FDA pages can change after publication, so use the live Drug Recalls page for the latest status. Our related FDA recall search guide explains how food and device systems differ.
The safest workflow is identifier-first and treatment-aware: verify the exact lot, involve the pharmacy or care team, follow the official remedy and never let an unverified social post or search snippet make a medication decision for you.
Comments
Comments are reviewed before publication. Do not post personal information, serial numbers, medical details, or emergency reports. For urgent safety concerns, use the official agency contact in the recall notice.
Sign in with Google to leave a comment
Loading comments...